Strategies for combination therapy in oncology: Part two – Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In...
Ashley Fraser is a principal in the Life Sciences Practice of Charles River Associates. She has over 16 years of experience advising pharmaceutical, biotech, and medical device organizations.
Her consulting experience includes pricing, reimbursement and market access strategies across the product development lifecycle, payer engagement, lifecycle management, and optimization of internal P&MA processes and team structures. Her engagements cover a range of therapeutic areas and emphasize Canada, US, and EU5 among other Global markets.